CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Current Assets:
Cash and cash equivalents	$ 20,136,789	$ 8,444,774
Receivables	255,007	62,765
Prepaid expenses	1,505,878	524,953
Supplies used for R&D and manufacturing	787,011	782,363
Total current assets	22,684,685	9,814,855
Finance lease right of use assets	14,241,298	0
Operating lease right of use assets	1,237,339	0
Property and equipment, net	3,762,633	15,825,636
Patent costs, net	311,346	311,586
Deposits	1,670,917	1,670,917
Total Assets	43,908,218	27,622,994
Current Liabilities:
Accounts payable	943,821	1,586,478
Accrued expenses	232,252	34,432
Due to employees	543,132	709,442
Derivative instruments, current portion	1,924,160	674,442
Lease liabilities, current portion	1,007,868	0
Other current liabilities	0	14,956
Total current liabilities	4,651,233	3,019,750
Derivative instruments, net of current portion	5,094,172	5,813,868
Finance lease obligations, net of current portion	11,995,197	13,508,156
Operating lease obligations, net of current portion	1,154,325	0
Other liabilities	125,000	147,553
Total liabilities	23,019,927	22,489,327
STOCKHOLDERS? EQUITY
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 38,522,236 and 35,231,776 shares issued and outstanding at June 30, 2020 and September 30, 2019, respectively	385,223	352,318
Additional paid-in capital	396,959,284	358,507,603
Accumulated deficit	(376,456,216)	(353,726,254)
Total stockholders' equity	20,888,291	5,133,667
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 43,908,218	$ 27,622,994